A combination of 5-fluorouracil and membrane-bound antibody inhibits B-cell lymphoma growth in a mouse model system.
Bonsignori
Mattia
M
D'Costa
Sybil
S
Surman
Sherri
S
Hurwitz
Julia L
JL
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D019013:CD40 Antigens / Q000276:immunology; D002462:Cell Membrane / Q000276:immunology / Q000378:metabolism*; D003131:Combined Modality Therapy; D004195:Disease Models, Animal; D005472:Fluorouracil / Q000627:therapeutic use*; D016393:Lymphoma, B-Cell / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D051379:Mice; D016513:Mice, SCID; D015996:Survival Rate; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D000964:Antimetabolites, Antineoplastic; D019013:CD40 Antigens; D005472:Fluorouracil